Meyer Handelman Company’s AstraZeneca AZN Stock Holding History

Meyer Handelman Company’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$372K	Hold	1,962	–	–	0.01%	199
2026 Q1	$386K	Buy	+1,962	New	+$378K	0.01%	189
2021 Q4	–	Sell	-5,225	Closed	-$628K	–	191
2021 Q3	$628K	Hold	5,225	–	–	0.03%	161
2021 Q2	$625K	Buy	+5,225	New	+$573K	0.02%	169
2020 Q4	–	Sell	-5,225	Closed	-$573K	–	189
2020 Q3	$573K	Buy	+5,225	New	+$581K	0.03%	155

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Meyer Handelman Company's AZN Position: Q2 2026 in Review

Meyer Handelman Company held its AstraZeneca (AZN) position steady in Q2 2026 at 1,962 shares worth $372K. The position accounts for 0.01% of the portfolio, ranked #199.

Meyer Handelman Company first reported a position in AZN in Q3 2020 and has held it in 5 quarters since. The position peaked at $628K in Q3 2021. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Meyer Handelman Company held 1,962 shares of AstraZeneca worth $372K as of Q2 2026.
Meyer Handelman Company left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.01% of Meyer Handelman Company's portfolio in Q2 2026, its #199 holding.
Meyer Handelman Company first reported a position in AstraZeneca in Q3 2020 and has held it in 5 quarters since.
Meyer Handelman Company's AstraZeneca position peaked at $628K in Q3 2021.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Meyer Handelman Company's 13F filing for Q2 2026, filed 3 Aug 2026.